(Q41657820)

6 October 2017

1 reference

title

What is required of an HIV vaccine? (English)

1 reference

6 October 2017

0 references

C R Bangham

1

1 reference

6 October 2017

R E Phillips

series ordinal

2

1 reference

6 October 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

6 October 2017

1 reference

6 October 2017

volume

350

1 reference

6 October 2017

issue

9091

1 reference

6 October 2017

page(s)

1617-1621

1 reference

Viral latency in HIV disease.

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Importance of the nef gene for maintenance of high virus loads and for development of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Antigenic oscillations and shifting immunodominance in HIV-1 infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Natural protection against HIV-1 infection provided by HIV-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Continuous and discontinuous protein antigenic determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Human antibodies that neutralize primary human immunodeficiency virus type 1 in vitro do not provide protection in an in vivo model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Can the immune response control HIV infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Emergence of virus escape mutants after immunization with epitope vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Long–term protection against SIV–induced disease in macaques vaccinated with a live attenuated HIV–2 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Vaccination with a live retrovirus: the nature of the protective immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

The role of antibody concentration and avidity in antiviral protection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

The daunting challenge of keeping HIV suppressed

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

Decay characteristics of HIV-1-infected compartments during combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903258-3

7 January 2021

10.1016/S0140-6736(97)03258-3

Identifiers

DOI

1 reference

6 October 2017

1 reference